texte alternatif                                    

    Liste de publications de Hugo Levillain


      Articles dans des revues avec comité de lecture (11)

  1. 1. Danieli, R., Stella, M., Leube, J., Tran-Gia, J., Marin, C., Uribe, C. F., Vanderlinden, B., Reynaert, N., Flamen, P., & Levillain, H. (2023). Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera. EJNMMI Physics, 10(1). doi:10.1186/s40658-023-00586-z
  2. 2. Bucalau, A.-M., Collette, B., Tancredi, I., Vouche, M., Pezzullo, M., Bouziotis, J., Moreno Reyes, M. R., Trotta, N., Levillain, H., Van Laethem, J.-L., & Verset, G. (2023). Clinical impact of 99mTc-MAA SPECT/ CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients. European journal of hybrid imaging.
  3. 3. Paquier, Z., Chao, S.-L., Bregni, G., Sanchez Corujo, A., Guiot, T., Dhont, J., Gulyban, A., Levillain, H., Sclafani, F., Reynaert, N., & Bali, M. A. (2022). Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation. Physica medica, 103, 138-146. doi:10.1016/j.ejmp.2022.10.009
  4. 4. Paquier, Z., Chao, S.-L., Acquisto, A., Fenton, C., Guiot, T., Dhont, J., Levillain, H., Gulyban, A., Bali, M. A., & Reynaert, N. (2022). Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values. Biomedical Physics & Engineering Express, 8(6), 065008. doi:10.1088/2057-1976/ac8e6f
  5. 5. Levillain, H., Bagni, O., Deroose, C. M., Dieudonné, A., Gnesin, S., Grosser, O. S., Kappadath, S. C., Kennedy, A., Kokabi, N., Liu, D., Madoff, D. C., Mahvash, A., Martinez de la Cuesta, A., Ng, D. C. E., Paprottka, P. M., Pettinato, C., Rodríguez-Fraile, M., Salem, R., Sangro, B., Strigari, L., Sze, D. Y., de Wit van der veen, B. J., & Flamen, P. (2021). International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. European journal of nuclear medicine and molecular imaging, 48(5), 1570-1584. doi:10.1007/s00259-020-05163-5
  6. 6. Levillain, H., Burghelea, M., Duran Derijckere, I., Guiot, T., Gulyban, A., Vanderlinden, B., Vouche, M., Flamen, P., & Reynaert, N. (2020). Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer. EJNMMI Physics, 7(1). doi:10.1186/s40658-020-00345-4
  7. 7. Karfis, I., Marin, G., Levillain, H., Drisis, S., Muteganya, R., Critchi, G., Taraji-Schiltz, L., Artigas Guix, C., Shaza, L., Elbachiri, M., Mans, L., Machiels, G., Hendlisz, A., & Flamen, P. (2020). Prognostic value of a three-scale grading system based on combining molecular imaging with 68Ga-DOTATATE and 18F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias. Oncotarget, 11(6), 589-599. doi:10.18632/oncotarget.27460
  8. 8. Artigas Guix, C., Flamen, P., Charlier, F., Levillain, H., Wimana, Z., Diamand, R., Albisinni, S., Gil, T., Van Velthoven, R., Peltier, A., Van Gestel, D., Roumeguere, T., & Otte, F.-X. (2019). 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy. World journal of urology. doi:10.1007/s00345-019-02701-1
  9. 9. Levillain, H., Duran Derijckere, I., Ameye, L., Guiot, T., Braat, A. A., Meyer, C., Vanderlinden, B., Reynaert, N., Hendlisz, A., Lam, M. M., Deroose, C. M., Ahmadzadehfar, H., & Flamen, P. (2019). Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study. European journal of nuclear medicine and molecular imaging. doi:10.1007/s00259-019-04427-z
  10. 10. Duran Derijckere, I., Levillain, H., Bohlok, A., Mathey, C., Nezri, J., Muteganya, R., Trotta, N., Lucidi, V., Bouazza, F., Germanova, D., Van Simaeys, G., Goldman, S., Hendlisz, A., Flamen, P., & Donckier De Donceel, V. (2019). The metabolic clinical risk score as a new prognostic model for surgical decision-making in patients with colorectal liver metastases. Journal of surgical oncology. doi:10.1002/jso.25763
  11. 11. Lemaire, M., Lucidi, V., Bouazza, F., Katsanos, G., Vanderlinden, B., Levillain, H., Delatte, P., Garcia, C., Vouche, M., Gomez-Galdon, M., Demetter, P., Deleporte, A., Hendlisz, A., Flamen, P., & Donckier De Donceel, V. (2018). Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study. HPB, 20(7), 641-648. doi:10.1016/j.hpb.2018.01.006
  12.   Thèses et mémoires (1)

  13. 1. Levillain, H. (2021). Prediction and improvement of radioembolization outcome using personalised treatment and dosimetry (Thèse doctorale non-publiée). Université libre de Bruxelles, Faculté de Médecine – Sciences biomédicales et pharmaceutiques, Bruxelles.